PUBLISHER: TechNavio | PRODUCT CODE: 1517254
PUBLISHER: TechNavio | PRODUCT CODE: 1517254
The transfection technologies market is forecasted to grow by USD 675.9 mn during 2023-2028, accelerating at a CAGR of 9.66% during the forecast period. The report on the transfection technologies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for monoclonal antibodies, continued developments in transfection technologies by market vendors, and growing adoption of CRISPR/CAS9 gene editing technology.
Technavio's transfection technologies market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 9.45% |
CAGR | 9.66% |
Incremental Value | $675.9mn |
By Type
By End-user
By Geographical Landscape
This study identifies the increased use of dual-reporter assays and co-transfection experiments as one of the prime reasons driving the transfection technologies market growth during the next few years. Also, optimization of transfection efficiency and growing focus on high-throughput transfection screening will lead to sizable demand in the market.
The report on the transfection technologies market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transfection technologies market vendors that include Altogen Biosystems, Bio RAD Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., GENLANTIS, ibidi GmbH, Inovio Pharmaceuticals Inc., Kytopen Corp., Life Technologies India Pvt Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OZ Biosciences, Promega Corp., QIAGEN NV, RJH BIOSCIENCES, Sartorius AG, SignaGen Laboratories, STEMCELL Technologies Inc., Takara Holdings Inc., and Thermo Fisher Scientific Inc.. Also, the transfection technologies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: